Nancy Valente

Affiliations

  • Evp, Chief Development Officer at Xencor Inc (XNCR), 2025-05-06
  • Director at Myovant Sciences Ltd. (MYOV), 2023-03-10
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
XNCR $11.03 4,616 $50,914.48 49,169 2025-05-02 Filing
XNCR $13.60 2,565 $34,876.56 53,785 2025-03-10 Filing
XNCR $23.58 4,745 $111,871.92 55,115 2024-05-02 Filing